Granules Pharmaceuticals Inc receives 6 observations from USFDA for Chantilly facility

Granules India Ltd has announced that the US FDA has completed an inspection of the facility of Granules Pharmaceuticals, Inc., a wholly-owned foreign subsidiary of the Company located in Chantilly, Virginia, the USA on 22nd July 2022 with six (6) observations. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time period.

Shares of Granules India Limited was last trading in BSE at Rs. 302.90 as compared to the previous close of Rs. 308.70. The total number of shares traded during the day was 47265 in over 1572 trades.

The stock hit an intraday high of Rs. 309.55 and intraday low of 298.00. The net turnover during the day was Rs. 14309326.00.

Source : Equity Bulls

Keywords

GranulesIndia INE101D01020 GranulesPharmaceuticals USFDA Inspection 6Observations Chantilly Virginia